Autobahn Therapeutics Completes Successful Pre-IND Meeting with FDA SAN DIEGO–(BUSINESS WIRE)– Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders, today announced it has … Continued